UBX
Unity Biotechnology
Delisted
UBX was delisted on the 8th of July, 2025.
42 hedge funds and large institutions have $204M invested in Unity Biotechnology in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 20 increasing their positions, 4 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 3.03% → 3.01% (-0.01%)
Holders
42
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$13.3M | |
| 2 | +$1.84M | |
| 3 | +$1.81M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.37M |
| 5 |
Morgan Stanley
New York
|
+$1.3M |
Top Sellers
| 1 | -$11.6M | |
| 2 | -$3.77M | |
| 3 | -$2.44M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$1.93M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$1.14M |